Clinical trials recruiting for Borderline Resectable Pancreatic Adenocarcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Folfirinox | 1 |
| HRS-4642+AG+Nimotuzumab | 1 |
| Isotoxic High-Dose (iHD)-SBRT | 1 |
| PTM-101 | 1 |
| Pembrolizumab | 1 |
| SABR | 1 |
| Standard Reagents, Pancreatic Cancer | 1 |
| mFOLFIRINOX or Gemcitabine nab-paclitaxel | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Michigan | 1 |
| New York | 1 |
| Texas | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
- HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
- Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
- PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
- Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
- Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
Related conditions
Trials recruiting for Borderline Resectable Pancreatic Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Borderline Resectable Pancreatic Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.